Latest Insider Positions


LUDLUM KEN is listed as an insider in the following companies: CDNA / CareDx, Inc. BABY / Natus Medical, Inc. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Holdings

Security Title Post Shares
BABY / Natus Medical Director 93,957
CDNA / CareDx Chief Financial Officer 48,000

Latest Transactions

Latest
Tran Date
Security Code Shares Post Shares Percent
Change
Share
Price
Tran
Value
Post
Value
Percent
Change
2018-08-02 BABY / Natus Medical S -3,000 93,957 -3.09 36.89 -110,670 3,466,074 -3.19
2018-08-02 BABY / Natus Medical M 3,000 96,957 3.19 24.50 73,500
2018-08-02 BABY / Natus Medical S -5,000 93,957 -5.05 36.89 -184,450 3,466,074 -5.32
2018-08-02 BABY / Natus Medical M 5,000 98,957 5.32 14.34 71,700
2018-06-22 BABY / Natus Medical A 4,132 93,957 4.60 36.30 149,992
2018-03-02 BABY / Natus Medical S -4,000 89,825 -4.26 31.675 -126,700 2,845,207 -4.45
2018-03-02 BABY / Natus Medical M 5,000 93,825 5.63 10.69 53,450
2017-06-21 BABY / Natus Medical A 4,100 88,825 4.84 35.60 145,960
2016-06-02 BABY / Natus Medical A 4,400 84,725 5.48 33.46 147,224
2016-02-17 BABY / Natus Medical S -117 160,767 -0.07 33 -3,861 5,305,311 -0.07
2016-02-16 BABY / Natus Medical S -6,508 160,767 -3.89 33.02 -214,894 5,308,526 -4.05
2016-01-22 CDNA / CareDx A 11,000 48,000 29.73
2015-06-04 BABY / Natus Medical A 3,250 86,950 3.88 40.61 131,982
2015-05-27 BABY / Natus Medical S -2,500 83,700 -2.90 36.57 -91,425 3,060,909 -2.99
2015-05-27 BABY / Natus Medical S -2,500 83,700 -2.90 36.57 -91,425 3,060,909 -2.99
2015-05-27 BABY / Natus Medical M 2,500 86,200 2.99 16.78 41,950
2015-05-27 BABY / Natus Medical S -2,500 83,700 -2.90 36.57 -91,425 3,060,909 -2.99
2015-05-27 BABY / Natus Medical M 2,500 86,200 2.99 16.38 40,950
2015-05-27 BABY / Natus Medical M 2,500 86,200 2.99 10.73 26,825
2015-03-06 CDNA / CareDx A 30,000 37,000 428.57
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)

Peers of LUDLUM KEN include the following: Abernethy Amy, BUHL CARSTEN, BYERS BROOK H, Bell Michael Brian, Bickerstaff George, CHUNG DONG CHUNE CHRISTOPHER, Cohen Fred E, Constanti Charles, DeFonzo Joshua, Engibous Doris, GAGNON NEIL, GUNST ROBERT A, Goldberg Michael, HAGSTROM WILLIAM A, HAWKINS JAMES B, Heine Lisa Wipperman, Karlsson Anders, Kennedy Jonathan, King Sasha, LEVINE JOSHUA, MILLER DOUGLAS S, MOORE WILLIAM M, Maag Peter, McDonnell Leslie L, Meyer Matthew J., Midroc Invest AB, Nelles Mitchell J, Noll Austin Francis III, PAUL BARBARA R, SNYDERMAN RALPH, Sninsky John Joseph, TRAVERSO KENNETH M, VILLAVERDE SHARON, Whitson Todd, Yee James P, . Peers are determined by cross-linking the filings of LUDLUM KEN with insider filings of others at the same companies.

Related News Stories

Natus Medical Inc. (BABY) CEO Jonathan Kennedy on Q2 2018 Results - Earnings Call Transcript

2018-07-25 seekingalpha
Natus Medical Inc. (NASDAQ:BABY) Q2 2018 Results Earnings Conference Call July 25, 2018 11:00 AM ET (1-0)

Natus Medical (BABY) Tops Q2 Earnings and Revenue Estimates

2018-07-25 zacks
Natus Medical (BABY - Free Report) just came out with quarterly earnings of $0.35 per share, beating the Zacks Consensus Estimate of $0.26 per share. This compares to earnings of $0.34 per share a year ago. These figures are adjusted for non-recurring items. (2-0)

Hedge fund Voce's nominees elected to Natus board

2018-06-22 reuters
(Reuters) - Natus Medical Inc said on Friday its stockholders had elected hedge fund Voce Capital Management’s nominees to the company’s board, ending a months long proxy fight. (5-0)

In Natus proxy fight, Glass Lewis supports Voce nominees

2018-06-13 reuters
BOSTON (Reuters) - Influential proxy-advisory firm Glass Lewis & Co recommended that Natus Medical Incorporated shareholders remove two company nominated directors and replace them with hedge fund Voce Capital Management’s nominees. (5-0)

Natus Medical's (BABY) CEO Jim Hawkins on Q1 2018 Results - Earnings Call Transcript

2018-04-25 seekingalpha
Ladies and gentlemen, thank you for standing by. Welcome to the Natus Medical First Quarter 2018 Financial Results Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded today, April 25, 2018 and contains time-sensitive information that is accurate only as of today. (5-0)